Cioppa GD - Search Results

1

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children.

Knuf M, Leroux-Roels G, Rümke H, Rivera L, Pedotti P, Arora AK, Lattanzi M, Kieninger D, Cioppa GD. Knuf M, et al. Among authors: cioppa gd. Hum Vaccin Immunother. 2015;11(2):358-76. doi: 10.4161/21645515.2014.987014. Hum Vaccin Immunother. 2015. PMID: 25621884 Free PMC article. Clinical Trial.

2

A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations.

Hatz C, Cramer JP, Vertruyen A, Schwarz TF, von Sonnenburg F, Borkowski A, Lattanzi M, Hilbert AK, Cioppa GD, Leroux-Roels G. Hatz C, et al. Among authors: cioppa gd. Vaccine. 2012 Jul 6;30(32):4820-7. doi: 10.1016/j.vaccine.2012.05.013. Epub 2012 May 22. Vaccine. 2012. PMID: 22626675 Clinical Trial.

3

Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children.

Nolan T, Bravo L, Ceballos A, Mitha E, Gray G, Quiambao B, Patel SS, Bizjajeva S, Bock H, Nazaire-Bermal N, Forleo-Neto E, Cioppa GD, Narasimhan V. Nolan T, et al. Among authors: cioppa gd. Vaccine. 2014 Oct 21;32(46):6146-56. doi: 10.1016/j.vaccine.2014.08.068. Epub 2014 Sep 16. Vaccine. 2014. PMID: 25223266 Clinical Trial.

4

Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.

Vesikari T, Forstén A, Herbinger KH, Cioppa GD, Beygo J, Borkowski A, Groth N, Bennati M, von Sonnenburg F. Vesikari T, et al. Among authors: cioppa gd. Vaccine. 2012 Feb 8;30(7):1388-96. doi: 10.1016/j.vaccine.2011.12.009. Epub 2011 Dec 20. Vaccine. 2012. PMID: 22192847 Clinical Trial.

5

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Busse W, et al. Among authors: cioppa gd. J Allergy Clin Immunol. 2001 Aug;108(2):184-90. doi: 10.1067/mai.2001.117880. J Allergy Clin Immunol. 2001. PMID: 11496232 Clinical Trial.

6

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD; Omalizumab 011 International Study Group. Holgate ST, et al. Among authors: cioppa gd. Clin Exp Allergy. 2004 Apr;34(4):632-8. doi: 10.1111/j.1365-2222.2004.1916.x. Clin Exp Allergy. 2004. PMID: 15080818 Clinical Trial.

7

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.

Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD. Bousquet J, et al. Among authors: cioppa gd. Allergy. 2005 Mar;60(3):302-8. doi: 10.1111/j.1398-9995.2004.00770.x. Allergy. 2005. PMID: 15679714

8

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis.

Adelroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, Byrne A, Champain K, Thirlwell J, Cioppa GD, Sandström T. Adelroth E, et al. Among authors: cioppa gd. J Allergy Clin Immunol. 2000 Aug;106(2):253-9. doi: 10.1067/mai.2000.108310. J Allergy Clin Immunol. 2000. PMID: 10932067 Clinical Trial.

9

The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics.

Wallin A, Sandström T, Cioppa GD, Holgate S, Wilson S. Wallin A, et al. Among authors: cioppa gd. Respir Med. 2002 Dec;96(12):1021-5. doi: 10.1053/rmed.2002.1388. Respir Med. 2002. PMID: 12477218 Free article. Clinical Trial.

10

Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.

Chuchalin AG, Manjra AI, Rozinova NN, Skopková O, Cioppa GD, Till D, Kaiser G, Fashola T, Kottakis J. Chuchalin AG, et al. Among authors: cioppa gd. J Aerosol Med. 2005 Spring;18(1):63-73. doi: 10.1089/jam.2005.18.63. J Aerosol Med. 2005. PMID: 15741775 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters